Royal Bank of Canada Increases Tenet Healthcare (NYSE:THC) Price Target to $104.00

Tenet Healthcare (NYSE:THC – Get Rating) had its price objective boosted by stock analysts at Royal Bank of Canada from $89.00 to $104.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 20.00% […]

Related Keywords

Canada ,Raymond James ,Ronalda Rittenmeyer ,Richardj Mark ,Mirabella Financial Services ,Norges Bank ,Invesco Ltd ,Tenet Healthcare Corporation ,Jefferies Financial Group ,Tenet Healthcare ,Tenet Healthcare Company Profile Get Rating ,Goldman Sachs Group ,Victory Capital Management Inc ,Royal Bank ,Get Rating ,Financial Group ,Chairman Ronald ,Director Richard ,Global Investors ,Financial Services ,Victory Capital Management ,Capital Management ,Healthcare Company Profile ,Healthcare Corporation ,Hospital Operations ,Ambulatory Care ,Nyse Thc ,Thc ,Medical ,88033g40 ,Boost Price Target ,Royal Bank Of Canada ,